DANIEL A. PRYOR - 27 Feb 2023 Form 4 Insider Report for Enovis CORP (ENOV)

Role
EVP, Strategy & Business Dev.
Signature
/s/ Brian P. Hanigan, attorney-in-fact
Issuer symbol
ENOV
Transactions as of
27 Feb 2023
Net transactions value
-$320,553
Form type
4
Filing time
01 Mar 2023, 19:00:44 UTC
Previous filing
23 Feb 2023
Next filing
08 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENOV Common stock, par value $0.001 Award $0 +10,341 +14% $0.000000 83,853 27 Feb 2023 Direct F1
transaction ENOV Common stock, par value $0.001 Sale $320,553 -5,716 -6.8% $56.08 78,137 27 Feb 2023 Direct F2
transaction ENOV Common stock, par value $0.001 Award $0 +7,862 +10% $0.000000 85,999 28 Feb 2023 Direct F3
transaction ENOV Common stock, par value $0.001 Award $0 +24,190 +28% $0.000000 110,189 28 Feb 2023 Direct F3
holding ENOV Common stock, par value $0.001 932 27 Feb 2023 By 401k plan
holding ENOV Common stock, par value $0.001 333 27 Feb 2023 By trust for daughter
holding ENOV Common stock, par value $0.001 333 27 Feb 2023 By trust for daughter
holding ENOV Common stock, par value $0.001 333 27 Feb 2023 By trust for son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENOV Employee Stock Option (right to buy) Award $0 +18,642 $0.000000 18,642 28 Feb 2023 Common stock, par value $0.001 18,642 $57.62 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the certification of the performance criteria for PRSUs previously awarded in 2020. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2021 Fiscal Year-End" table on page 45 of Enovis Corporation's proxy statement as filed with the Securities and Exchange Commission on April 28, 2022.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax withholding obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units.
F3 This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.
F4 The option vests in three equal annual installments beginning on the first anniversary of the grant date.